ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
U.S. biotechnology companies are withholding more research details to prevent Chinese competitors from replicating their innovations. The strategy involves filing fewer patent applications and limiting disclosures in scientific publications. This shift aims to protect intellectual property in a highly competitive global market.
Tap to vote and see what everyone thinks.
Summary by ByteBrief